Advertisement

Topics

FibroGen nets $309.7mm via FOPO

15:40 EDT 18 Aug 2017 | Elsevier Business Intelligence

FibroGen Inc. (developing therapies for anemia, fibrotic disease, and cancer) netted $309.7mm through a follow-on offering of...

Original Article: FibroGen nets $309.7mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "FibroGen nets $309.7mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...